Skip to content

Slovenia logo

Main menu
  • Preglednost
  • Stopite v stik z nami

Main menu

Organon site directory

  • Organon

    • Brazil
    • Canada  English  ·  French
    • Latin America
    • Mexico
    • USA
  • Organon

    • Austria
    • Belgium  Dutch  ·  English  ·  French
    • Bulgaria
    • Czech Republic
    • Denmark
    • Estonia
    • Finland
    • France
    • Germany
    • Hungary
    • Ireland
    • Italy
    • Latvia
    • Lithuania
    • Luxembourg  English  ·  French
    • Netherlands  Dutch  ·  English
    • Norway
    • Poland
    • Portugal
    • Romania
    • Russia
    • Serbia
    • Slovakia
    • Slovenia
    • Spain
    • Sweden
    • Switzerland  French  ·  German  ·  English
    • Ukraine  Ukrainian  · 
    • United Kingdom
  • Organon

    • Australia
    • Hong Kong, China
    • Indonesia
    • Japan
    • Malaysia
    • New Zealand
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Organon

    • Egypt
    • Israel
    • Jordan
    • KSA
    • Kuwait
    • Lebanon
    • Northwest Africa  French  ·  Arabic  ·  Turkey
    • Oman
    • South Africa
    • Turkey
    • UAE
View all locations and contact information

What can we help you find?

Search for:

Preglednost

Organon se zavezuje k trajnostnemu poslovanju v vseh poslovnih dejavnostih in si prizadeva izpolnjevati najvišje etične, družbene in okoljske standarde.

Integriteta in transparentnost

V Organonu si prizadevamo za odprtost in transparentnost glede našega načina dela. Zavezani smo poštenemu, natančnemu in pravočasnemu razkritju informacij o našem poslovanju, da bi ohranili zaupanje ne le splošne in strokovne javnosti, temveč tudi naših zaposlenih in delničarjev.

Etični kodeks ravnanja družbe Organon
Foreign Corrupt Practices Act (FCPA)

Zavezanost transparentnosti

V Organonu si prizadevamo, da so informacije, ki jih posredujemo našim deležnikom, dosledne in natančne, pri čemer se skladno z zakonodajo držav, v katerih poslujemo, in kodeksi sektorja držimo naslednjih ključnih načel:

  1.                Transparentnost je temelj našega poslovanja. Poštenost, celovitost in preglednost informacij – ter pravočasno razkritje teh informacij na agregirani osnovi – omogočajo ključnim deležnikom, da sprejemajo informirane odločitve o našem podjetju in naših zdravilih.
  2.           Zdravstveni delavci, zdravstvene organizacije, društva pacientov, finančna nadomestila in donacije Spoštujemo našo zavezo, da razkrijemo prenose sredstev zdravstvenim delavcem in zdravstvenim organizacijam v skladu z lokalnimi zakoni in predpisi, da bi tako spodbujali preglednost in preprečili morebitna navzkrižja interesov.

Metodologija

Javna objava prenosov sredstev

Javna objava prenosov sredstev zdravstvenim delavcem in zdravstvenim organizacijam s strani farmacevtskih družb se izvaja izključno zaradi preglednosti, v skladu z določbami Kodeksa EFPIA (Evropska zveza farmacevtskih družb in Farmaforum.

Slovenia logo
  • Politika piškotkov
  • Politika zasebnosti
Copyright © 2025 Podjetje ORGANON, Vse pravice pridržane. ORGANON in logotip ORGANON sta blagovni znamki podjetja Organon VeevaPM SL-NON-110000. Date of preparation 10/2024.

You are leaving Organon.com

Cancel Continue Opens a new window

Forward-looking statement of Organon

This news release of Organon (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. There can be no guarantees with respect to pipeline products that the products will receive the necessary regulatory approvals or that they will prove to be commercially successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.

Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of the recent global outbreak of novel coronavirus disease (COVID-19); the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.

The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s 2020 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov Opens a new window ).

No Duty to Update

The information contained in this website was current as of the date presented. The company assumes no duty to update the information to reflect subsequent developments. Consequently, the company will not update the information contained in the website and investors should not rely upon the information as current or accurate after the presentation date.

Decline Accept